Brian J. Aneskievich
Professor/Pharmaceutical Science
Storrs Mansfield
Are you Brian J. Aneskievich?
How to update your information.
Scholarly Contributions
69 Scholarly Contributions
Identification and Characterization of Transcriptional Control Elements Regulating a Novel Receptor-Mediated Signaling Regulator, TNIP1.
2012
Research Type: Poster/Presentation
TNIP1 is a Novel Transcriptional Repressor of Heat Shock Protein A6
2012
Research Type: Poster/Presentation
TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locations.
2011
Research Type: Journal Article
Receptor Control of Human Skin Cell Regeneration and Maturation
2011
Research Type: Poster/Presentation
Heat Shock Protein A1A and A6 Transcriptional Regulation by TNIP1
2011
Research Type: Poster/Presentation
Characterization of Transcriptional Control Elements Regulating a Novel Receptor-Mediated Signaling Regulator, TNIP1.
2011
Research Type: Poster/Presentation
Developing a new integrated dermatology course for pharmacy students
2011
Research Type: Poster/Presentation
Developing a new integrated dermatology course for pharmacy students.
2010
Research Type: Journal Article
Enzyme association with PPAR Evidence of a new role for 15lipoxygenase type 2
2005
Research Type: Journal Article
Isolation and functional analysis of a keratinocytederived ligandregulated nuclear receptor comodulator
2004
Research Type: Journal Article
FHL2 expression in keratinocytes and transcriptional effect on PPARRXR 1
2004
Research Type: Journal Article
Deletion of RAR carboxyl terminus reveals promoter and receptorspecific AF1 effects
2001
Research Type: Journal Article
Induction of cell migration on synthetic polymer substrates through tailored cellsubstrate matrix reciprocity
1999
Research Type: Journal Article
Epitheliumspecific response of cultured keratinocytes to infection with adenovirus type 2
Research Type: Conference Proceedings
Cellular partitioning of beta1 integrins and their phosphorylated forms is altered after transformation by Rous sarcoma virus or treatment with cytochalasin D
Research Type: Conference Proceedings